79 /100
CRITICAL RISK
Score updated May 28, 2026

FOXO — FOXO Technologies Inc. Dilution Risk Tracker

Track FOXO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track FOXO — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
95
📊 Float Risk
15
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌩️
Severe
Multiple high-probability dilution events detected
75%
💰 Capital Raise 93%
• Critical: only 0.3 months cash remaining
• Active shelf registration ($1000M, 234650% of market cap)
🔁 Convertible Conversion 60%
• Major convertible overhang: 6570% potential dilution
• Convertible risk score very high (85/100)
📉 Score Deterioration 55%
• Score rose 61 points recently (worsening)
• Score already CRITICAL (79/100) — events likely imminent
🔔 Track FOXO — Get forecast alerts →

💹 Market Data

Market Cap$426.2K
Shares Outstanding4.26B
Float4.01B
Cash$65.9K
Debt$2.92M
Short InterestN/A

🏛 Institutional Holdings

5.8% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track FOXO for full holder detail →

📉 Short Interest

Short Interest1.9K
Days to Cover1.0
% of FloatN/A
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Jun 30, 2023
424B3 ATM Feb 11, 2026
EFFECT EFFECT Feb 11, 2026
S-1 SHELF Feb 09, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track FOXO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking FOXO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for FOXO
📊 FOXO FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 FOXO Signal Convergence & Dark Pool Activity — StonkWhisper 📄 FOXO Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.